AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND THOMAS DONNELLYAgreement by And • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
Agreement made on August 7, 2017 ("Execution Date") by and between Thomas Donnelly ("Consultant"), a natural person whose address is at 44 Rue Bourgelat, 94700 Maisons-Alfort, FRANCE and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND Todd S. CavenEmployment Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 21, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Todd S. Caven ("Employee").
ContractBusiness Advisory Board Services Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
This Business Advisory Board Services Agreement (the “Agreement”), dated June 23, 2017, is entered into between Zander Therapeutics, Inc., a Nevada corporation (“the Company), and Brian Devine, an individual with a principal place of residence California(“Candidate”).
EMPLOYMENT AGREEMENT BETWEEN ZANDER THERAPEUTICS, INC. AND Harry M. Lander, Ph.D., M.B.A.Employment Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
THIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of August 5, 2017 is entered into between Zanderr Therapeutics, Inc., a Nevada corporation, (the "Company") and Harry M. Lander ("Employee").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the ''Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the (“Company'') whose address is
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated September 12, 2017Agreement by And • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
ContractAgreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
Agreement made on March 20, 2017 (“Execution Date”) by and between Linda Black (“Consultant”), a natural person whose address is ___________and Entest BioMedical Inc.
AMENDED AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND JONATHAN BAELLAmended Agreement • November 30th, 2017 • Entest Biomedical, Inc. • Pharmaceutical preparations • California
Agreement made on August 16, 2017 ("Execution Date") by and between Jonathan Baell ("Consultant"), a natural person whose address is at 53 Glenard Drive, Eaglemont, VICTORIA 3084 Australia and Zander Therapeutics, Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942. Consultant and Company may be referred to individually as "Party" and collectively as "Parties".
Agreement between Value Quest Inc. and Entest BioMedical Inc.Entest Biomedical, Inc. • November 30th, 2017 • Pharmaceutical preparations • California
Agreement by and between Value Quest Inc. ("Consultant"), whose address is at East Chase Street, St 1103, Baltimore, MD 21202 and Entest BioMedical Inc. ("Company"), a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942 made as of July 17, 2017.
